Literature DB >> 18979589

Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18979589

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  38 in total

1.  Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges.

Authors:  Madkuhar Pai; Kevin Elwood
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

3.  Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women.

Authors:  S R Jonnalagadda; E Brown; B Lohman-Payne; D Wamalwa; C Farquhar; G C John-Stewart
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

Review 4.  Preventing and treating biologic-associated opportunistic infections.

Authors:  Kevin L Winthrop; Tom Chiller
Journal:  Nat Rev Rheumatol       Date:  2009-07       Impact factor: 20.543

Review 5.  Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.

Authors:  Geoffrey C Nguyen; Shane M Devlin; Waqqas Afif; Brian Bressler; Steven E Gruchy; Gilaad G Kaplan; Liliana Oliveira; Sophie Plamondon; Cynthia H Seow; Chadwick Williams; Karen Wong; Brian M Yan; Jennifer Jones
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

6.  Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?

Authors:  D I Ling; M Pai; V Davids; L Brunet; L Lenders; R Meldau; G Calligaro; B Allwood; R van Zyl-Smit; J Peter; E Bateman; R Dawson; K Dheda
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

7.  Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection-2010 Update: An Advisory Committee Statement (ACS) Canadian Tuberculosis Committee (CTC)*†.

Authors:  Dennis Kunimoto; Drs Michael Gardam; Ian Kitai; Dick Menzies; Muhammad Morshed; Madhukar Pai; Heather Ward; Duncan Webster; Wendy Wobeser
Journal:  Can Commun Dis Rep       Date:  2010-06-01

8.  Application and interpretation of an interferon-gamma release assay: Results of an audit in a Canadian centre.

Authors:  Sopharat Vat; Marc Ghannoum; Pierre Laflamme; Mario Dugas; Manon Labrecque; Valéry Lavergne
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

9.  Short-term reproducibility of a commercial interferon gamma release assay.

Authors:  A K Detjen; L Loebenberg; H M S Grewal; K Stanley; A Gutschmidt; C Kruger; N Du Plessis; M Kidd; N Beyers; G Walzl; A C Hesseling
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

Review 10.  Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review.

Authors:  Richard N van Zyl-Smit; Alice Zwerling; Keertan Dheda; Madhukar Pai
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.